• TRADE NAMES: Arlevert; Cerepar; Cinarizins; Cinazyn; Cinnabene; Cinnacet; Cinnageron; Cinnarisine; Cinnipirine; Clinadil; Derozin; Diclamina; Ederal; Libotacin; Medozine; Pericephal; Pervasum; Sepan; Stugeron (Janssen); Surepil; Sureptil; Touristil; Vertizin (Ram)
  • INDICATIONS: Dizziness, tinnitus, nystagmus, nausea and vomiting, motion sickness
  • CLASS: Histamine H1 receptor antagonist, Muscarinic antagonist, Vasodilator, peripheral
  • HALF-LIFE: 4 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Alcohol, Barbiturates, Hypnotics, Narcotic analgesics, Sedatives, Tranquilizers, Tricyclic antidepressants

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric